filmov
tv
icglaucoma.org
A personalized approach to the treatment and monitoring of patients with AMD and glaucoma
What are the mechanisms of angle closure? Do we consider all of them in the clinical practice?
00x Disscusion 2
Discussion eng
Long-Term Risk and Prediction of Progression in Primary Angle Closure Suspect. BY Xu, USA
MONITORING OF VARIOUS FORMS OF GLAUCOMA: “WHAT? WHEN? WHY?” (INTERACTIVE SESSION WITH THE REGIONS)
Multi-dimensional imaging model for screening of primary open angle glaucoma. G. Wang, China
03 Shpak A A
00x Disscusion 1
DISCUSSION
02 Likhvantseva V G
04 Ningli Wang
The special features of optic neuropathy and its progression in PACG.
00x Дискуссия 3 и подведение итогов 1
06 Kurysheva N I
How can we personalize the PACG treatment? (G.Gazzard, UK)
00 Introduction
OCT biomarkers for personalized treatment of AMD patients, Maltsev D., Russia
MONITORING OF THE ANGLE-CLOSURE GLAUCOMA: SEVERAL MOST CONTROVERSIAL PROBLEMS
Discussion (1)
Jeffrey LIEBMANN. PERFUSION, PHENOTYPE AND PROGRESSION
PPP-medicine concepts to glaucoma treatment and monitoring. Kurysheva N., Russia
PACG: Epidemiology, prevalence and anatomical risk factors.Do we need to change the classification?
